Bofumustine
Product Specifications
UNSPSC Description
Bofumustine (ICIG 1105) is a nitrosourea compound with antitumor activity. Bofumustine can interfere with the replication and division of tumor cell DNA through alkylation, leading to the death of tumor cells. Bofumustine can be used in the field of cancer research[1].
Target Antigen
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bofumustine.html
Smiles
ClCCN(N=O)C(NC1[C@@]2([H])[C@@](OC(C)(C)O2)([H])[C@@H](COC(C3=CC=C([N+]([O-])=O)C=C3)=O)O1)=O
Molecular Weight
472.83
References & Citations
[1]Jun Sun, et al. Anticarcinogen composition carried with both nitrosourea type medicine and guanine analog. CN101045059A. 2007-04-28
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-106052/Bofumustine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-106052/
Clinical Information
No Development Reported
CAS Number
55102-44-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
